Plain-English translation of NCT07896772 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study is looking at a hormone called anti-Müllerian hormone (AMH) and several other hormones in women with breast cancer. Researchers want to understand what these hormone levels look like in women at different points in their breast cancer treatment, and compare them to healthy women without breast cancer. The goal is to see whether measuring these hormones regularly could become a useful part of routine breast cancer care.
Breast cancer treatment can affect a woman's hormones and fertility, but doctors don't yet know whether checking these hormone levels as part of regular care would be helpful. This study is exploring that question by collecting hormone data from women with breast cancer and healthy volunteers to see if routine hormone testing is practical and could guide future treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you have breast cancer, the study uses blood samples your doctor is already planning to take as part of your regular care—no extra needle sticks are needed. If you are a healthy volunteer, you will come in for one blood draw and answer a few quick questions about your medical history. In both cases, researchers will also review your medical records to gather relevant information.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
Czechia
Enrollment target
~200 participants
Started
November 2025
Primary completion
June 2027
Age range
20 Years – 55 Years
Sex
Female only
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Iveta Selingerova, Ph.D.
Masaryk Memorial Cancer Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.